WeVote
Log In

Bill

Bill

SB 1127

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions; and providing for disposable menstrual product label requirements.

2025-2026 Regular Session Introduced by Amanda Cappelletti and 12 co-sponsors

Disposable menstrual products in Pennsylvania would require standardized labeling under the Drug, Device and Cosmetic Act.

Referred to Health & Human Services
0
WeVote Research Nonpartisan
Bill Summary · SB 1127

Summary of SB 1127 (Pennsylvania, 2025-2026)

Purpose and intent

SB 1127 proposes amendments to The Controlled Substance, Drug, Device and Cosmetic Act (Act of April 14, 1972, P.L. 233, No. 64) to add new definitions and establish labeling requirements for disposable menstrual products. The bill aims to improve consumer information and safety related to menstrual hygiene products.

Key provisions and changes

  • Definitions: The bill would add or modify definitions within the Act to clarify terms used in relation to disposable menstrual products. While exact definitional language is not provided here, the intent is to standardize terminology surrounding these products under the broader drug, device, cosmetic framework.
  • Label requirements for disposable menstrual products: The core substantive change is the requirement that disposable menstrual products carry specified labeling. This could include information such as ingredients, safety warnings, usage instructions, and any other information deemed necessary by the act to inform consumers.
  • Scope: The labeling requirements would apply to disposable menstrual products within the regulatory purview of the Pennsylvania Controlled Substances, Drug, Device and Cosmetic Act. This aligns menstrual products under the act’s existing framework for devices and cosmetics, ensuring regulatory oversight of labeling and related disclosures.
  • Compliance and enforcement: While not detailed in the provided summary, such label requirements typically include compliance timelines, penalties for noncompliance, and a mechanism for enforcement (e.g., inspections, recalls, or civil penalties). The bill would likely set a timetable for manufacturers and distributors to ensure labeling meets the new standards.

Who/what would be affected

  • Manufacturers and distributors of disposable menstrual products sold in Pennsylvania would be directly impacted, as they would need to update product labels to meet the new requirements.
  • Retailers and suppliers would be affected insofar as they must stock labeled products that meet the statute.
  • Consumers would gain access to standardized labeling on disposable menstrual products, potentially improving safety information and product understanding.
  • Regulatory agencies enforcement would oversee compliance with the new labeling standards under the Act’s framework.

Procedural and timeline considerations

  • Status: Referred to the Health & Human Services committee on 2025-12-29, indicating the bill is in the early legislative stage and awaiting committee review, hearings, and possible amendments.
  • Sponsors: A broad slate of co-sponsors from both legislative chambers, including Maria Collett, Judy Schwank, Vincent Hughes, Amanda Cappelletti, Carolyn Comitta, Steve Santarsiero, Sharif Street, Lindsey Williams, John Kane, Art Haywood, Jay Costa, Tina Tartaglione, and Tim Kearney, suggesting cross-chamber support and interest.
  • Next steps (typical for such a bill): Committee consideration, potential amendments, hearings to gather stakeholder input (manufacturers, consumer groups, health experts), and votes in committee followed by floor votes in the Senate and House, and eventually a governor’s signature or veto. Specific timing would depend on the legislative agenda and committee schedule.

Practical considerations and potential impact

  • Consumer safety and information: Standardized labels could improve consumer understanding of product contents, usage, and safety precautions.
  • Regulatory alignment: Bringing disposable menstrual products under explicit labeling requirements within the Act may harmonize oversight with other cosmetic and device products.
  • Industry impact: Manufacturers may incur costs to redesign labels, update packaging, and ensure ongoing compliance with labeling standards. Smaller manufacturers could be disproportionately affected depending on the final labeling requirements and transition period.

If you’d like, I can tailor this summary to focus on a particular stakeholder (e.g., manufacturers, consumers, or policymakers) or compare it with existing labeling practices for menstrual products in Pennsylvania or other states.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.